Dr Ravin Ratan on Advancing Sarcoma Care at ASCO 2024
May 29th 2024In this interview ahead of the 2024 American Society of Clinical Oncology annual meeting (ASCO), Ravin Ratan, MD, MEd, The University of Texas MD Anderson Cancer Center, discusses study data he is excited to hear more about on the combination of trabectedin and low-dose irinotecan for relapsed/refractory Ewing sarcoma.
Watch
Immunological Events Indicated in Onset of Hypersomnolence Disorders, Study Finds
May 29th 2024Findings from a retrospective study suggested a possible causal relationship between prior infection and the development of hypersomnolence disorders such as narcolepsy and idiopathic hypersomnia, but more research is needed.
Read More
Patients With Diabetes and Heart Failure May Face Worse Outcomes, Increased HFpEF Risk
May 29th 2024According to new research from Jordan, patients with both heart failure (HF) and diabetes had a higher prevalence of HF with preserved ejection fraction (HFpEF), elevated cholesterol, low-density lipoprotein, and impaired kidney function.
Read More
Pegcetacoplan Contributes to Better Outcomes in PNH vs Other Treatments
May 29th 2024An analysis of 2 phase 3 trials supporting the use of pegcetacoplan (PEG) in the treatment of paroxysmal nocturnal hemoglobinuria (PNH) assessed the benefits of this treatment compared with eculizumab (ECU) and supportive care measures.
Read More
Scientists are worried that fertilized hen eggs remain the main ingredient for the H5N1 bird flu vaccine; an increased risk of preterm delivery and stillbirth exists in the US due to the worsening climate; health care executives are discussing whether they should bring in outside consultants or hire more employees in preparation for cyberattacks.
Read More
Primary Cicatricial Alopecia Connected to Increased Risk of Endocrine, Metabolic Diseases
May 28th 2024A study using a large Korean health database found that people with a rare hair loss disorder called primary cicatricial alopecia were more likely to also have additional health problems like diabetes and high blood pressure compared with people who had other hair loss conditions or no hair loss at all.
Read More
The Impact of COVID-19 on Asthma Diagnosis, Health Care Utilization
May 28th 2024Posters presented at the American Thoracic Society (ATS) 2024 International Conference examined factors of the pandemic that may have influenced the clinical presentation and diagnosis of respiratory symptoms, as well as health care resource utilization for serious asthma outcomes.
Read More
Exercise, Diet Interventions Boost Fat-Free Mass, Reduce Fatigue in Patients With OC
May 28th 2024Exercise and dietary interventions reduced fatigue and improved both fat-free mass and physical functioning in patients with ovarian cancer (OC), but no significant differences in improvement were found between the intervention and control groups.
Read More
ATS 2024 Review: Innovative Treatments and Health Equity Take Center Stage
May 28th 2024Among the many topics discussed at the American Thoracic Society 2024 International Conference (ATS 2024), the majority touched on barriers to health equity and access, regardless of the key focus of each talk or study. Experts examined this within the field, emphasizing the importance of enhancing data diversity, modernizing diagnostic tools, and revising regulatory standards to promote equitable health outcomes for diverse populations.
Read More
Early BP Reduction Shows No Benefit in Acute Stroke, but Outcomes May Vary by Stroke Type
May 27th 2024A study found that prehospital blood pressure (BP) reduction had no impact on functional outcomes among patients with undifferentiated acute stroke, but that it may decrease the odds of poor outcomes following hemorrhagic stroke.
Read More
Ponatinib, Imatinib Face Off, but Still Room for TKI Improvement in Ph+ ALL
May 26th 2024Interim results of the randomized, phase 3 PhALLCON trial indicate ponatinib’s benefit over imatinib in frontline treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), but questions linger about ponatinib’s long-term safety.
Read More
Body Composition Changes Linked to Poor NSCLC Outcomes
May 24th 2024For this analysis of how body composition might affect the impact of immunotherapy used to treat non–small cell lung cancer (NSCLC), investigators from Dana-Farber Brigham Cancer Center compared patient outcomes based on baseline body composition measurements or first follow-up scan.
Read More
Many US dairy farms have not yet increased bird flu protections for employees despite the outbreak in cows; the human papillomavirus (HPV) vaccine is linked to a drastic reduction in head and neck cancers in adolescent boys and men; the World Health Organization recently accused tobacco companies of actively trying to hook a new generation on nicotine.
Read More
Harnessing AI for Improved Outcomes in Hidradenitis Suppurativa Management
May 24th 2024An Italian review highlighted the potential of AI to enhance early diagnosis and treatment of hidradenitis suppurativa, though challenges such as data privacy, algorithm bias, and interpretability must be addressed to fully leverage AI's benefits in dermatology.
Read More